Brendan Smith
No más puestos en curso
Fortuna: 345 708 $ al 31/03/2024
Perfil
En la actualidad, Brendan Smith ocupa el cargo de Vicepresidente Senior, Director Financiero y Contable de CRISPR Therapeutics AG. Anteriormente, el Sr. Smith fue Director Financiero y Jefe de Estrategia Corporativa en Translate Bio, Inc. y Socio y Director Asociado en The Boston Consulting Group, Inc. Se licenció en el Worcester Polytechnic Institute y obtuvo un MBA en la Harvard Business School.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
CRISPR THERAPEUTICS AG
0.01% | 31/03/2023 | 5 072 ( 0.01% ) | 345 708 $ | 31/03/2024 |
Antiguos cargos conocidos de Brendan Smith.
Empresas | Cargo | Fin |
---|---|---|
CRISPR THERAPEUTICS AG | Director of Finance/CFO | 14/03/2023 |
TRANSLATE BIO, INC. | Director of Finance/CFO | 14/09/2021 |
The Boston Consulting Group, Inc.
The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Corporate Officer/Principal | 01/03/2021 |
Pfizer AG | Director/Board Member | - |
Formación de Brendan Smith.
Worcester Polytechnic Institute | Undergraduate Degree |
Harvard Business School | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
CRISPR THERAPEUTICS AG | Health Technology |
Empresas privadas | 3 |
---|---|
Translate Bio, Inc.
Translate Bio, Inc. BiotechnologyHealth Technology Translate Bio, Inc. engages in the research and development of therapeutic drugs. It focuses on developing medicines to treat diseases caused by protein or gene dysfunction. Its lead product candidate, MRT5005 is designed for the treatment of cystic fibrosis. The company was founded by Arthur M. Krieg and Jeannie T. Lee in 2011 and is headquartered in Lexington, MA. | Health Technology |
The Boston Consulting Group, Inc.
The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Commercial Services |
Pfizer AG |
- Bolsa de valores
- Insiders
- Brendan Smith